A recent report published by Infinium Global Research on RNA therapy market provides an in-depth analysis of segments and sub-segments in the global as well as regional RNA therapy market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional RNA therapy market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global RNA therapy market. According to the report, the global RNA therapy market is projected to grow at a CAGR of 8.5% over the forecast period of 2019-2025.
RNA therapy is more accurate and targeted therapy because it targets particular protein, by not harming other proteins in the cell. RNA based therapy is more customized then many other drugs used in inherent and genetic disorders. The of RNA therapeutics consists of several different kinds of technologies, including RNA interference (RNAi) therapeutics, antisense therapies, nucleic acid or peptide aptamers and microRNA therapeutics. RNA therapy to treat a wide variety of diseases, including cardiovascular disease, hemophilia, and cancer. increased number of viral disease globally is fueling the demand for RNA therapy.
Rising genetic diseases, neurological disorders, and viral infections are the major factors driving the RNA therapy market. Advancement in the sectors of molecular technology, nanotechnology, and biology is likely to boost the RNA therapy market. Completion of the human genome project has provided target sequences in ample amount giving an opportunity for the development of RNA based therapeutics. Moreover, rising biotechnology industries are contributing to the growth of RNA therapy market. However, high cost associated with detection kits and analytical instruments can hamper the growth of RNA therapy market. RNA therapies are less toxic and provide a number of advantages over chemotherapy, that can provide better opportunities for RNA therapy market.
Amongst the geographical region, North America holds the largest market share in RNA therapy market owing to conducting widespread research to commercialize the therapeutics. Europe is second largest in the growth of RNA therapy market. The emergence of various infectious diseases, genetic disease and neurological diseases in this region contribute to the growth of RNA therapy market in these regions. The Asia Pacific is one of the fastest growing market owing to technological advances making it more effective and consumable hence, boosting the growth of RNA therapy market.
The report on global RNA therapy market covers segments such as technology, and application. On the basis of technology, the sub-markets include enabling technologies, enabled technologies, RNA antisense technologies, and RNA interference (RNAi) technologies. On the basis of application, the sub-markets include kidney diseases, cardiovascular, infectious diseases, oncology, metabolic disorders, and other applications.
The report provides profiles of the companies in the market such as Silence Therapeutics, Cenix BioScience GmbH, Sanofi Genzyme, Benitec Biopharma Ltd, Arbutus Biopharma Corporation, DiceRNA Pharmaceuticals, Alnylam Pharmaceuticals Inc., Quark Pharmaceuticals, and Other Companies.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of RNA therapy market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter